phase i study shows nivolumab is safe and tolerable for relapsed or refractory hodgkin lymphoma
Published 9 years ago • 101 plays • Length 7:51Download video MP4
Download video MP3
Similar videos
-
2:23
phase i trial of nivolumab shows significant benefit for hodgkin's lymphoma, mayo clinic
-
7:40
nivolumab shows early promise in hodgkin lymphoma
-
18:46
relapsed or refractory classical hodgkin lymphoma - with dr robin gasiorowski. eha 2020
-
7:57
ash2014: philippe armand - nivolumab in patients with relapsed or refractory hodgkin lymphoma
-
3:56
phase i study of tinostamustine in pre-treated patients with r/r hodgkin lymphoma
-
3:05
nivolumab in patients with relapsed or refractory classical hodgkin lymphoma
-
43:47
relapsed and refractory hodgkin lymphoma
-
1:23
ipilimumab, nivolumab & brentuximab vedotin for r/r hodgkin lymphoma
-
11:29
an international phase ii trial of single-agent nivolumab for hodgkin lymphoma relapsed or refrac...
-
1:56
the abscopal effect of radiotherapy and nivolumab in relapsed or refractory hodgkin lymphoma
-
1:14
checkmate 205 study results: nivolumab in classical hodgkin lymphoma
-
7:24
phase iii study shows brentuximab improves progression-free survival in hodgkin lymphoma
-
1:21
checkmate 205: the use of nivolumab to treat relapsed hodgkin lymphoma
-
5:25
blocking pd-1 activity could be safe and effective in classical hodgkin lymphoma
-
5:01
relapsed & refractory classic hodgkin lymphoma
-
18:55
how i manage advanced stage hodgkin lymphoma and what do i do at first relapse
-
4:24
relapsed and refractory hodgkin lymphoma
-
3:09
phase i trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma
-
2:24
nivolumab for relapsed hodgkin lymphoma clinical trial | weill cornell medical college | new york